According to a meta-analysis published in an oncology journal, angiotensin-receptor blockers are associated with a modestly increased risk for cancer. Researchers examined date from five randomized studies including more than 62,000 patients. They found those taking ARBs had a significantly greater risk for new cancer than did the controls. When analyzing different cancer types, lung cancer was the greatest increased risk. The authors of the study call the increase risk “modest” and the mechanism of why there is an increased cancer risk “uncertain.” One ARB in particular used in the study was telmisartan, approximately 85% of patients studied. Often ARBs are used as an alternate treatment for patients who do not tolerate ACE inhibitors. Guidelines from the study suggest that ARBs should be used with greater caution and ACE inhibitors to be used when tolerated.
Dr. Kerry Ferguson
Popular Posts
-
Ingredient: 2 tablespoons Homemade Ghee or sunflower oil, divided 4 medium carrots (cut into small circles) 2 yellow beets (scrubbed and... -
Ingredients 1 cup dried apricots 1/2 cup dates, pitted 1/2 cup almonds 1/4 cup coconut Directions Place all the ingredients in a ... -
What are Fruit Anthocyanins? Our Fruit Anthocyanins are an organic dark fruit and berry concentrate designed by Dr. Wi... -
Ingredients 2 cups packed cilantro 1/4 cup walnuts 1/2 lemon, juiced 2 garlic cloves 2 tablespoons olive oil 1/8 teaspoon sea salt ... -
Our Fruit Anthocyanins are an organic dark fruit and berry concentrate designed by Dr. William Mitchell, who pioneered its use as a power... -
Heaps of juicy pomegranate seeds and a smooth layer of creamy chocolate go together beautifully in this treat. Offer it as a gift, or make i...
"Follow"
"Like"
Website
